Further work is required to clarify the relationship between membrane‐bound granzyme A, plasma granzyme A, and CSF granzyme A. Plausible interpretations of these data are that this may be an effect of treatment—which we attempt to address—and potentially a feature of accelerated immune aging in MS. This evidence concerns the gene GZMA and myeloid sarcoma.